Full name: LHFPL3 antisense RNA 1 | Alias Symbol: | ||
Type: non-coding RNA | Cytoband: 7q22.2 | ||
Entrez ID: 645591 | HGNC ID: HGNC:40341 | Ensembl Gene: ENSG00000226869 | OMIM ID: |
Drug and gene relationship at DGIdb |
Expression of LHFPL3-AS1:
Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
---|---|---|---|---|---|---|
GSE17351 | LHFPL3-AS1 | 645591 | 1554302_s_at | -0.0106 | 0.9714 | |
GSE26886 | LHFPL3-AS1 | 645591 | 1554302_s_at | 0.0074 | 0.9496 | |
GSE45670 | LHFPL3-AS1 | 645591 | 1554302_s_at | 0.0656 | 0.3585 | |
GSE53622 | LHFPL3-AS1 | 645591 | 12472 | 0.1832 | 0.1567 | |
GSE53624 | LHFPL3-AS1 | 645591 | 12472 | 0.2667 | 0.0417 | |
GSE63941 | LHFPL3-AS1 | 645591 | 1554302_s_at | 0.0409 | 0.7701 | |
GSE77861 | LHFPL3-AS1 | 645591 | 1554302_s_at | -0.0928 | 0.4115 |
Upregulated datasets: 0; Downregulated datasets: 0.
Survival by LHFPL3-AS1 expression:
Note: Click image to view full size file.
Copy number change of LHFPL3-AS1:
Dataset | Gene | EntrezID | Gain | Loss | Normal | Detail |
---|---|---|---|---|---|---|
GSE15526 | LHFPL3-AS1 | 645591 | 14 | 0 | 16 | |
GSE20123 | LHFPL3-AS1 | 645591 | 14 | 0 | 16 | |
GSE43470 | LHFPL3-AS1 | 645591 | 7 | 1 | 35 | |
GSE46452 | LHFPL3-AS1 | 645591 | 10 | 1 | 48 | |
GSE47630 | LHFPL3-AS1 | 645591 | 7 | 3 | 30 | |
GSE54993 | LHFPL3-AS1 | 645591 | 2 | 10 | 58 | |
GSE54994 | LHFPL3-AS1 | 645591 | 16 | 3 | 34 | |
GSE60625 | LHFPL3-AS1 | 645591 | 0 | 0 | 11 | |
GSE74703 | LHFPL3-AS1 | 645591 | 7 | 1 | 28 | |
GSE74704 | LHFPL3-AS1 | 645591 | 9 | 0 | 11 |
Total number of gains: 86; Total number of losses: 19; Total Number of normals: 287.
Somatic mutations of LHFPL3-AS1:
Generating mutation plots.
Highly correlated genes for LHFPL3-AS1:
Showing all 4 correlated genes with mean PCC>0.5.
Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
---|---|---|---|---|---|
LHFPL3-AS1 | DLX2 | 0.658236 | 3 | 0 | 3 |
LHFPL3-AS1 | ADAM18 | 0.611513 | 3 | 0 | 3 |
LHFPL3-AS1 | DPYSL5 | 0.608006 | 3 | 0 | 3 |
LHFPL3-AS1 | OR51B4 | 0.51743 | 4 | 0 | 3 |
For details and further investigation, click here